A new drug discovery and development company is taking root in Madison, and it will prevent more than a dozen skilled scientists here from losing their jobs.
Nimble Therapeutics formed in April, spun out of Roche Sequencing Solutions, originally NimbleGen Systems, which is slated to close by June 2020.